MEA PDE Inhibitors Market

Middle East and Africa PDE Inhibitors market Size ( 2024 to 2029)

The size of the Middle East and Africa PDE Inhibitors market is predicted to be growing at a sluggish rate from 2024 to 2029.

The high sales and market growth of PDE-5 have encouraged pharmaceutical manufacturers to invest more money in further research of PDE Inhibitors market.

This is expected to be a key driving factor of the market. Increasing awareness of people towards usage of PDE Inhibitors is propelling the market size. The PDE Inhibitors market is segmented by Application and by Drug Type. By Application, the market is categorized into Erectile Dysfunction, Cardiovascular Diseases, Benign Prostate Hyperplasia, Respiratory Diseases, Neurological Diseases, Dermatological Disorders, Pulmonary Hypertension, Others. By Drug type, the market is further divided into PDE-1, PDE-2, PDE-3, PDE-4, PDE-5, Viagra, Cialis, Levitra, and others. The increasing demand for PDE-5 from the pediatric patients suffering from Pulmonary Hypertension has helped it to occupy the major market share. Besides, PDE-5 can also be used to treat patients suffering from erectile dysfunction and minor heart attacks, this can further fuel the market size. From the recent studies, we can easily conclude that PDE-5 can be safely suggested to infants and children suffering from Pulmonary Hypertension which can also be attributed to increasing the size of the PDE Inhibitors market. The PDE-4 inhibitor which is used in treating atopic dermatitis and skin disorders is also expected to increase its demand as some of its key manufacturers received FDA approval regarding its production.

By geography, the market is segmented into Middle East and Africa. The majority of the market is centred around UAE and South Africa and is expected to have a study growth in the forecast period.

KEY MARKET PLAYERS

Some of the major manufacturers in the PDE Inhibitors Market are Mist Pharmaceuticals, AstraZeneca, Nusirt Biopharma, Takeda Pharmaceuticals, Bayer AG, Pfizer, Otsuka, Eli Lilly, Verona Pharma, Omeros, Hanmi Science Holding, Celgene Corporation.